HRGN — Harvard Apparatus Regenerative Technology Share News
0.000.00%
Last trade - 00:00- $39.80m
- $39.95m
- $0.70m
Brief: Harvard Apparatus Regenerative Tech says will need additional testing of hart-trachea
Brief: Harvard Apparatus files for mixed shelf of up to $20 mln
Brief: Harvard Apparatus Regenerative Technology to no longer provide hart-trachea product in Russia
Brief: Harvard Apparatus Regenerative Technology reports operating results for the third quarter ended September 30, 2014
Brief: Harvard Apparatus Regenerative Technology updates patient status
Market Pulse: BlackBerry, Extreme Networks, World Acceptance, UTStarcom